BSE filing, NSE: SOLARA. Summary written from the filing by ALFA Finder's alert engine.
Solara Active Pharma Sciences Ltd: key numbers
- Share price
- ₹666.30
- Market cap
- ₹3,210 Cr
- Revenue (annual)
- ₹1,369 Cr
- Net profit (annual)
- ₹-7.41 Cr
- P/E (TTM)
- 86.9×Sector 48.6×
- Promoter holding
- 41.93%+0.00% QoQ
- FII holding
- 10.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Solara Active Pharma Sciences Ltd
All →Solara Active Pharma Sciences Other Announcement
Solara Active Pharma Sciences Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure details equity ownership across various investor categories.
Solara Active Pharma Sciences Earnings Call Transcript: Key Takeaways
Solara delivered its best profitability in five years despite ongoing Ibuprofen pricing and raw material challenges.
Solara Active Pharma Sciences Investor Presentation: Key Takeaways
Solara's Q2 FY27 delivered record EBITDA and PAT in five years, driven by 33% revenue growth. Base business strength offset Ibuprofen headwinds, which is now nearing breakeven.
Solara Active Pharma Sciences Employee Stock Options
Solara Active Pharma Sciences Limited allotted 8,300 equity shares under its 2018 ESOP plan. The exercise of these options realized Rs. 0.31 Crore for the company.
- Value
- ₹0.31 Cr
Solara Active Pharma Sciences Q2 FY27 Results: Turns Profitable, Net Profit ₹28.5 Cr
Solara Active Pharma Sciences Ltd reported revenue from operations of ₹417.3 Cr (+33.1% YoY) and net profit of ₹28.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹28.5 Cr
Solara Active Pharma Sciences Other Announcement
Solara Active Pharma received an ESG rating of 63 ('Strong' category) from Crisil ESG Ratings for the fiscal year 2026, an upgrade from the prior year.
Other annual general meeting announcements
All →Khazanchi Jewellers Annual General Meeting
Khazanchi Jewellers' EGM on November 17, 2026 approved Ms. Simran Lodha's appointment as Independent Director for three years. The resolution was a special resolution passed via e-voting.
Prataap Snacks Annual General Meeting
Prataap Snacks issued a postal ballot notice seeking approval to appoint Jitendra Nayyar and Sumit Sharma as directors and to reclassify some promoter group members as public. Voting ends December 18, 2026.
Sayaji Hotels Annual General Meeting
Sayaji Hotels filed a postal ballot notice seeking shareholder approval to appoint two non-executive non-independent directors. E-voting runs from 18 November to 18 December 2026.
Bliss GVS Pharma Annual General Meeting
Bliss GVS Pharma's postal ballot sought approval to appoint three Non-Executive Non-Independent Directors. The voting results show all three resolutions passed with majority approval.
Coreintegra Consulting Services Annual General Meeting
Coreintegra seeks postal ballot approval to vary IPO fund objects and utilise Rs 15.15 Crore of unutilised proceeds. E-voting runs until 17 December 2026.
- Value
- ₹15.15 Cr
- Execution
- E-voting from 18 November 2026 (09:00 a.m.) to 17 December 2026 (05:00 p.m.)
Valor Estate Annual General Meeting
Valor Estate issued a postal ballot notice seeking approval for a related-party consultancy and cost auditor remuneration. E-voting runs until December 17, 2026.
- Execution
- 3 years from 5 November 2026 (Item 1 consultancy term)